{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:34:26Z","timestamp":1775856866723,"version":"3.50.1"},"reference-count":22,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.5387\/fms.2018-01","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T18:37:38Z","timestamp":1535481458000},"page":"89-94","source":"Crossref","is-referenced-by-count":20,"title":["Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum"],"prefix":"10.5387","volume":"64","author":[{"given":"Makiko","family":"Yashiro","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Gastroenterology, Japanese Red Cross Fukushima Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol, <b>54<\/b>: 597-613, 2006.","DOI":"10.1016\/j.jaad.2005.10.041"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Sato S, Hirakata M, Kuwana M , <i>et al<\/i>. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum, <b>52<\/b>: 1571-1576, 2005.","DOI":"10.1002\/art.21023"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum, <b>60<\/b>: 2193-2200, 2009.","DOI":"10.1002\/art.24621"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Abe Y, Matsushita M, Tada K, Yamaji K, Takasaki Y, Tamura N. Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis. Rheumatology,<b> 56<\/b>: 1492-1497, 2017.","DOI":"10.1093\/rheumatology\/kex188"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, <i>et al<\/i>. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology, <b>53<\/b>: 2196-2203, 2014.","DOI":"10.1093\/rheumatology\/keu258"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Gono T, Kawaguchi Y, Satoh T, <i>et al<\/i>. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology, <b>49<\/b>: 1713-1719, 2010.","DOI":"10.1093\/rheumatology\/keq149"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol, <b>22<\/b>: 639-643, 2010.","DOI":"10.1097\/BOR.0b013e32833f1987"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Hall JC, Casciola-Rosen L, Samedy LA, <i>et al<\/i>. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res, <b>65<\/b>: 1307-1315, 2013.","DOI":"10.1002\/acr.21992"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Matsushita T, Mizumaki K, Kano M, <i>et al<\/i>. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol, <b>176<\/b>: 395-402, 2017.","DOI":"10.1111\/bjd.14882"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Koga T, Fujikawa K, Horai Y,<i> <\/i><i>et al<\/i>. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology, <b>51<\/b>: 1278-1284, 2012.","DOI":"10.1093\/rheumatology\/ker518"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.  Tsuda T, Asanuma Y, Koyama S, Kawabata Y, Moriguchi M. A case of hypomyopathic dermatomyositis associated with rapid progressive interstitial pneumonia resistant to multi-immunosuppressive therapy. Am J Med Sci, <b>333<\/b>: 185-190, 2007.","DOI":"10.1097\/MAJ.0b013e318031b122"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.  Kurita T, Yasuda S, Amengual O, Atsumi T. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis\/dermatomyositis. Lupus, <b>24<\/b>: 3-9, 2012.","DOI":"10.1177\/0961203314554849"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Ando M, Miyazaki E, Yamasue M, Sadamura Y, Ishii T, Takenaka R, Ito T, Nureki S, Kumamoto T. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol, <b>29<\/b>: 443-445, 2010.","DOI":"10.1007\/s10067-009-1358-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.  Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem, <b>7<\/b>: 731-748, 2000.","DOI":"10.2174\/0929867003374723"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.  Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C, Fietta A, Vitulo P, Pozzi E, Vigan\u00f2 M. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc, <b>35<\/b>: 1523-1526, 2003.","DOI":"10.1016\/S0041-1345(03)00476-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16.  Wynn TA. Cellular and molecular mechanisms of fibrosis. J Patho, <b>214<\/b>: 199-210, 2008.","DOI":"10.1002\/path.2277"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, <i>et al<\/i>. Polymyositis-dermatomyositis and infections. Autoimmunity, <b>39<\/b>: 191-196, 2006.","DOI":"10.1080\/08916930600622348"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.  Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, <i>et al<\/i>. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology, <b>51<\/b>: 1563-1570, 2012.","DOI":"10.1093\/rheumatology\/kes102"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Sato S, Kuwana M, Fujita T, Suzuki Y. Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol, <b>23<\/b>: 496-502, 2013.","DOI":"10.3109\/s10165-012-0663-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Ma X, Chen Z, Hu W, Guo Z, Wang Y, Kuwana M, Sun L. Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum. Clin Rheumatol, <b>35<\/b>: 489-493, 2012.","DOI":"10.1007\/s10067-015-3001-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Le Goff B, Ch\u00e9rin P, Cantagrel A, <i>et al<\/i>. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum, <b>61: <\/b>108-118, 2009.","DOI":"10.1002\/art.24372"},{"key":"22","unstructured":"22.  Jansen TL, Barrera P, van Engelen BG, Cox N, Laan RF, van de Putte LB. Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature. Clin Exp Rheumatol, <b>16<\/b>: 733-735, 1998."}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/64\/2\/64_2018-01\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:35:54Z","timestamp":1535762154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/64\/2\/64_2018-01\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2018-01","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}